News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FDA Reports Current Drgu Shortage for Teva Parenteral Medicines, Inc. (TEVA)'s Zanosar (Streptozocin) Injection



8/26/2008 2:31:43 PM

San Francisco, Calif., -- The FDA reports a current drug shortages for Zanosar (Streptozocin) Injection due to manufactering delays. The drug is manufactered by Teva Parenteral Medicines, Inc.

Please call 1-888-TevaUSA for more information.

Visit the FDA. for additional information on this and other current drug shortages.

Contact Suvarna Bhatt at sbhatt@biospace.com.


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES